Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver T Keppler

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
The European Respiratory Journal|February 19, 2021
Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patientsDieter Munker, Andreas Osterman, Hans Stubbe, et al.
Blood|July 19, 2021
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike proteinAndreas Greinacher, Kathleen Selleng, Julia Mayerle, et al.
Journal of Medical Virology|January 6, 2025
SARS-CoV-2 Productively Infects Human Hepatocytes and Induces Cell DeathChunkyu Ko, Cho-Chin Cheng, Daniele Mistretta, et al.
Infection|May 12, 2025
Effective surveillance of acute COVID-19 using a cost- and labor-efficient approach: a paradigm for the longitudinal monitoring of respiratory infections in larger cohortsPaul R Wratil, Niklas A Schmacke, Burak Karakoc, et al.
Cell Reports|December 21, 2021
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronavirusesPaul R Wratil, Niklas A Schmacke, Burak Karakoc, et al.
Nature Medicine|December 20, 2016
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Nature Cancer|December 21, 2022
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myelomaAndrea Keppler-Hafkemeyer, Christine Greil, Paul R Wratil, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2020
Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumoniaLeo Nicolai, Alexander Leunig, Sophia Brambs, et al.
Nature Communications|September 23, 2022
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infectionElham Khatamzas, Markus H Antwerpen, Alexandra Rehn, et al.
Nature Medicine|January 28, 2022
Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concernPaul R Wratil, Marcel Stern, Alina Priller, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
The European Respiratory Journal|February 19, 2021
Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patientsDieter Munker, Andreas Osterman, Hans Stubbe, et al.
Blood|July 19, 2021
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike proteinAndreas Greinacher, Kathleen Selleng, Julia Mayerle, et al.
Journal of Medical Virology|January 6, 2025
SARS-CoV-2 Productively Infects Human Hepatocytes and Induces Cell DeathChunkyu Ko, Cho-Chin Cheng, Daniele Mistretta, et al.
Infection|May 12, 2025
Effective surveillance of acute COVID-19 using a cost- and labor-efficient approach: a paradigm for the longitudinal monitoring of respiratory infections in larger cohortsPaul R Wratil, Niklas A Schmacke, Burak Karakoc, et al.
Cell Reports|December 21, 2021
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronavirusesPaul R Wratil, Niklas A Schmacke, Burak Karakoc, et al.
Nature Medicine|December 20, 2016
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Nature Cancer|December 21, 2022
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myelomaAndrea Keppler-Hafkemeyer, Christine Greil, Paul R Wratil, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2020
Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumoniaLeo Nicolai, Alexander Leunig, Sophia Brambs, et al.
Nature Communications|September 23, 2022
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infectionElham Khatamzas, Markus H Antwerpen, Alexandra Rehn, et al.
Nature Medicine|January 28, 2022
Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concernPaul R Wratil, Marcel Stern, Alina Priller, et al.
Pageof 15